核酸材料介导的癌症天生的免疫激活 免疫疗法
Xinyu Xu1, Yuxuan Hong1, Huanhuan Fan1
1State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, 210023, China.
ChemMedChem
|April 16, 2024
概括
核酸材料 (NAMs) 通过模仿病原体相关分子模式 (PAMPs) 来激活天生的免疫力. 这些NAM通过刺激抗瘤免疫反应,显示出癌症免疫疗法的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
背景情况:
- 异常局部化的核酸 (NA) 在先天免疫中充当病原体相关分子模式 (PAMP).
- 通过模式识别受体 (PRR) 识别NA,触发免疫信号,产生I型干扰素和促炎细胞因子.
- 通过NA介导的免疫激活取决于PRR聚合,受NA长度,度和结构等特征的影响.
研究的目的:
- 讨论核酸材料 (NAMs) 介导的先天免疫反应的机制.
- 总结NAM在癌症免疫治疗中的应用.
- 突出NAM在临床癌症治疗中的潜力.
主要方法:
- 关于核酸材料 (NAM) 和它们在天生的免疫力中的作用的现有文献的审查.
- 分析NA特征如何影响PRR聚合和免疫激活.
- 检查临床前数据,证明NAM在癌症免疫疗法模型中的有效性.
主要成果:
- 具有高价值和有序结构的核酸材料 (NAM) 可以有效地激活先天性和适应性免疫力.
- 在临床前癌症模型中,各种NAM已经显示出显著的抗瘤免疫力.
- 在癌症免疫疗法中,NAM显示出临床应用的潜力.
结论:
- 由于其激活免疫反应的能力,NAMs是癌症免疫治疗的有希望的候选者.
- 了解NA-PRR相互作用是设计有效的基于NAM的治疗方法的关键.
- 对NAM的进一步研究可能会导致癌症治疗的新策略.
相关概念视频
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Cytotoxic T Cells-mediated Immune Response
904
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
904
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Cancer Vaccines
360
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
Antigens Involved in Adaptive Immunity
487
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
487


